Literature DB >> 29358413

The Hypoxia-Adenosine Link during Intestinal Inflammation.

Jessica L Bowser1, Luan H Phan2, Holger K Eltzschig1.   

Abstract

Intestinal inflammation is a key element in inflammatory bowel disease and is related to a combination of factors, including genetics, mucosal barrier dysfunction, bacteria translocation, deleterious host-microbe interactions, and dysregulated immune responses. Over the past decade, it has been appreciated that these inflammatory lesions are associated with profound tissue hypoxia. Interestingly, an endogenous adaptive response under the control of hypoxia signaling is enhancement in adenosine signaling, which impacts these different endpoints, including promoting barrier function and encouraging anti-inflammatory activity. In this review, we discuss the hypoxia-adenosine link in inflammatory bowel disease, intestinal ischemia/reperfusion injury, and colon cancer. In addition, we provide a summary of clinical implications of hypoxia and adenosine signaling in intestinal inflammation and disease.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29358413      PMCID: PMC5784778          DOI: 10.4049/jimmunol.1701414

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  179 in total

1.  Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity.

Authors:  Eoin P Cummins; Edurne Berra; Katrina M Comerford; Amandine Ginouves; Kathleen T Fitzgerald; Fergal Seeballuck; Catherine Godson; Jens E Nielsen; Paul Moynagh; Jacques Pouyssegur; Cormac T Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

2.  Control of creatine metabolism by HIF is an endogenous mechanism of barrier regulation in colitis.

Authors:  Louise E Glover; Brittelle E Bowers; Bejan Saeedi; Stefan F Ehrentraut; Eric L Campbell; Amanda J Bayless; Evgenia Dobrinskikh; Agnieszka A Kendrick; Caleb J Kelly; Adrianne Burgess; Lauren Miller; Douglas J Kominsky; Paul Jedlicka; Sean P Colgan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

3.  Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia.

Authors:  G R Strohmeier; W I Lencer; T W Patapoff; L F Thompson; S L Carlson; S J Moe; D K Carnes; R J Mrsny; J L Madara
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

4.  A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection.

Authors:  Cheryl Y M Okumura; Andrew Hollands; Dan N Tran; Joshua Olson; Samira Dahesh; Maren von Köckritz-Blickwede; Wdee Thienphrapa; Courtney Corle; Seung Nam Jeung; Anna Kotsakis; Robert A Shalwitz; Randall S Johnson; Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2012-02-28       Impact factor: 4.599

5.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

6.  A2A adenosine receptor protects tumors from antitumor T cells.

Authors:  Akio Ohta; Elieser Gorelik; Simon J Prasad; Franca Ronchese; Dmitriy Lukashev; Michael K K Wong; Xiaojun Huang; Sheila Caldwell; Kebin Liu; Patrick Smith; Jiang-Fan Chen; Edwin K Jackson; Sergey Apasov; Scott Abrams; Michail Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-17       Impact factor: 11.205

7.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

8.  Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion.

Authors:  S Huang; S Apasov; M Koshiba; M Sitkovsky
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

9.  HIF-dependent induction of adenosine A2B receptor in hypoxia.

Authors:  Tianqing Kong; Karen A Westerman; Marion Faigle; Holger K Eltzschig; Sean P Colgan
Journal:  FASEB J       Date:  2006-11       Impact factor: 5.191

10.  HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia.

Authors:  Holger K Eltzschig; Parween Abdulla; Edgar Hoffman; Kathryn E Hamilton; Dionne Daniels; Caroline Schönfeld; Michaela Löffler; German Reyes; Michael Duszenko; Jorn Karhausen; Andreas Robinson; Karen A Westerman; Imogen R Coe; Sean P Colgan
Journal:  J Exp Med       Date:  2005-12-05       Impact factor: 14.307

View more
  27 in total

1.  Monocyte glycolysis determines CD8+ T cell functionality in human Chagas disease.

Authors:  Liliana María Sanmarco; Natalia Eberhardt; Gastón Bergero; Luz Piedad Quebrada Palacio; Pamela Martino Adami; Laura Marina Visconti; Ángel Ramón Minguez; Yolanda Hernández-Vasquez; Eugenio Antonio Carrera Silva; Laura Morelli; Miriam Postan; Maria Pilar Aoki
Journal:  JCI Insight       Date:  2019-09-19

Review 2.  Extracellular nucleotide signaling in solid organ transplantation.

Authors:  Scott Yeudall; Norbert Leitinger; Victor E Laubach
Journal:  Am J Transplant       Date:  2019-11-04       Impact factor: 8.086

3.  Metabolite, protein, and tissue dysfunction associated with COVID-19 disease severity.

Authors:  Ali Rahnavard; Brendan Mann; Abhigya Giri; Ranojoy Chatterjee; Keith A Crandall
Journal:  Sci Rep       Date:  2022-07-16       Impact factor: 4.996

Review 4.  MicroRNA miR-223 as regulator of innate immunity.

Authors:  Xiaoyi Yuan; Nathaniel Berg; Jae Woong Lee; Thanh-Thuy Le; Viola Neudecker; Na Jing; Holger Eltzschig
Journal:  J Leukoc Biol       Date:  2018-07-03       Impact factor: 4.962

5.  Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation.

Authors:  Luca Antonioli; Carolina Pellegrini; Matteo Fornai; Laura Benvenuti; Vanessa D'Antongiovanni; Rocchina Colucci; Lorenzo Bertani; Clelia Di Salvo; Giorgia Semeghini; Concettina La Motta; Laura Giusti; Lorenzo Zallocco; Maurizio Ronci; Luca Quattrini; Francesco Angelucci; Vito Coviello; Won-Keun Oh; Quy Thi Kim Ha; Zoltan H Németh; Gyorgy Haskó; Corrado Blandizzi
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

Review 6.  Synapomorphic features of hepatic and pulmonary vasculatures include comparable purinergic signaling responses in host defense and modulation of inflammation.

Authors:  Dusan Hanidziar; Simon C Robson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-06-09       Impact factor: 4.871

7.  Inhibition of A2B Adenosine Receptor Attenuates Intestinal Injury in a Rat Model of Necrotizing Enterocolitis.

Authors:  Lie Huang; Juan Fan; Yan-Xiang Chen; Jian-Hui Wang
Journal:  Mediators Inflamm       Date:  2020-07-03       Impact factor: 4.711

8.  Interaction between Tumor-Associated Dendritic Cells and Colon Cancer Cells Contributes to Tumor Progression via CXCL1.

Authors:  Ya-Ling Hsu; Yi-Jen Chen; Wei-An Chang; Shu-Fang Jian; Hsiao-Li Fan; Jaw-Yuan Wang; Po-Lin Kuo
Journal:  Int J Mol Sci       Date:  2018-08-16       Impact factor: 5.923

Review 9.  The elegant complexity of mammalian ecto-5'-nucleotidase (CD73).

Authors:  Karel P Alcedo; Jessica L Bowser; Natasha T Snider
Journal:  Trends Cell Biol       Date:  2021-06-08       Impact factor: 21.167

Review 10.  Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?

Authors:  Tiziana Vaisitti; Francesca Arruga; Silvia Deaglio
Journal:  Int J Mol Sci       Date:  2018-04-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.